pre-IND – is an acronym for pre-investigational new drug. As new therapies are being developed, they reach a stage where testing is ready to begin. In the US, the FDA requires that an IND application be filed before testing begins.
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated